Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/8/2020
SIETES contiene 93083 citas

 
 
 1 a 17 de 17 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Robblee JV, Butterfield RJ, Kang AM, Smith JM. Triptan and ergotamine overdoses in the United States. Analysis of the National Poison Data System. Neurology 2020:1. [Ref.ID 103505]
2.
Seymour HE, Worsley A, Smith JM, Thomas SHL. Anti-TNF agents for rheumatoid arthritis. Br J Clin Pharmacol 2001;51:201-8. [Ref.ID 55489]
3.
Campbell M, Young PI, Bateman DN, Smith JM, Thomas SHL. The use of atypical antipsychotics in the management of schizophrenia. Br J Clin Pharmacol 1999;47:13-22. [Ref.ID 44568]
4.
Devine OJ, Smith JM. Estimating sample size for epidemiologic studies: the impact of ignoring exposure measurement uncertainty. Clin Pharmacol Ther 1998;63:1375-89. [Ref.ID 39165]
5.
Narayan S N, Cain ME, Smith JM. Atrial fibrillation. Lancet 1997;350:943-50. [Ref.ID 35418]
6.
Lee A, Bateman N, Edwards C, Smith JM, Rawlins M D. Reporting of adverse drug reactions by hospital pharmacists: pilot scheme. BMJ 1997;315:519. [Ref.ID 34772]
7.
Bateman DN, Campbell M, Roberts S J, Smith JM, Donaldson LJ. Prescribing incentive scheme for non-fundholding general practices. Authors' reply. BMJ 1996;313:1484. [Ref.ID 30642]
8.
Smith JM. Effectively costing out options. JAMA 1996;276:1180. [Ref.ID 29481]
9. Cita con resumen
Bateman DN, Campbell M, Donaldson LJ, Roberts S J, Smith JM. A prescribing incentive scheme for non-fundholding general practices: an observational study. BMJ 1996;313:535-8. [Ref.ID 28960]
10.
Campbell M, Bateman DN, Lee A, Smith JM, Beaney A. The pros and cons of generic medicines. Pharmacoeconomics 1995;8:362-3. [Ref.ID 24846]
11. Cita con resumen
Roberts S J, Bateman DN, Smith JM. Changes in primary care prescribing in the Northern Region UK: 1989-1992. Pharmacoepidemiol Drug Saf 1994;3:73-83. [Ref.ID 22692]
12.
Campbell M, Bateman DN, Smith JM. Analysis of GP prescribing in the Northern region using PACT data. Br J Clin Pharmacol 1992;34:184P. [Ref.ID 18677]
13.
Skene AI, Smith JM, Doré CJ, Charlett A, Lewis JD. Venous leg ulcers: a prognostic index to predict time to healing. BMJ 1992;305:1119-21. [Ref.ID 18243]
14.Tiene citas relacionadas Cita con resumen
Ferner RE, Smith JM. Lithium and pregnancy. Lancet 1992;339:869. [Ref.ID 17135]
15. Cita con resumen
Bateman DN, Lee A, Rawlins M D, Smith JM. Geographical differences in adverse drug reactions reporting rates in the Northern Region. Br J Clin Pharmacol 1991;31:188-9. [Ref.ID 15984]
16. Cita con resumen
Bateman DN, Smith JM. A policy for laxatives. BMJ 1988;297:1420-1. [Ref.ID 11996]
17.
Chaplin S, Smith JM. Data sheet warnings about drug safety in pregnancy. Lancet 1987;2:516. [Ref.ID 11148]
Seleccionar todas
 
 1 a 17 de 17